Arcutis Biotherapeutics Inc — Quarterly Cash Flow (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 437.35 M348.89 M344.11 M352.43 M370.98 M432.97 M Total liabilities 280.71 M191.35 M201.45 M213.46 M212.9 M243.49 M Total equity 156.64 M157.54 M142.66 M138.97 M158.07 M189.48 M Total liabilities & shareholders' equities 437.35 M348.89 M344.11 M352.43 M370.98 M432.97 M Total debt —————— Net debt ——————

Noticias

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham eleva el precio objetivo de Arcutis a 36 dólares por fuertes ventas

Needham eleva precio objetivo de Arcutis a $36 por sólidas ventas

Needham raises Arcutis stock price target to $36 on strong sales

H.C. Wainwright eleva el precio objetivo de Arcutis por las sólidas ventas de Zoryve

H.C. Wainwright eleva precio objetivo de Arcutis por sólidas ventas de Zoryve

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis T4 2025: ZORYVE impulsa rentabilidad, supera ingresos

Arcutis T4 2025: ZORYVE impulsa rentabilidad, supera ingresos